|
Volumn 35, Issue , 1998, Pages 691-730
|
Iron chelators for clinical use.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFEROXAMINE;
DRUG DERIVATIVE;
EDETIC ACID;
FERRIC ION;
IRON;
IRON CHELATING AGENT;
LIGAND;
N,N' BIS(2 HYDROXYBENZYL)ETHYLENEDIAMINE N,N' DIACETIC ACID;
N,N' BIS(DIBENZYL)ETHYLENEDIAMINEDIACETIC ACID;
N,N'-BIS(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID;
N,N'-BIS(DIBENZYL)ETHYLENEDIAMINEDIACETIC ACID;
PENTETIC ACID;
RAZOXANE;
SCAVENGER;
CHEMISTRY;
DRUG DELIVERY SYSTEM;
HUMAN;
IRON OVERLOAD;
METABOLISM;
MOLECULAR WEIGHT;
OXIDATION REDUCTION REACTION;
REVIEW;
SOLUBILITY;
STRUCTURE ACTIVITY RELATION;
TISSUE DISTRIBUTION;
TRANSPORT AT THE CELLULAR LEVEL;
BIOLOGICAL TRANSPORT;
DEFEROXAMINE;
DRUG DELIVERY SYSTEMS;
EDETIC ACID;
FERRIC COMPOUNDS;
FREE RADICAL SCAVENGERS;
HUMANS;
IRON;
IRON CHELATING AGENTS;
IRON OVERLOAD;
LIGANDS;
MOLECULAR WEIGHT;
OXIDATION-REDUCTION;
PENTETIC ACID;
RAZOXANE;
SOLUBILITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
TISSUE DISTRIBUTION;
|
EID: 0031612367
PISSN: 01615149
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (92)
|
References (65)
|